Market cap
$103 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
19.2
Div. Yield
0 %
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
Market cap ($ Mln) |
103 | 478 | 163 |
Revenue ($ Mln) |
-- | 192 | 12 |
Net Profit ($ Mln) |
-31.50 | 22.25 | -20.18 |
Net Margin (%) |
-- | 11.60 | -170.10 |
RoE (%) |
-385.07 | 8.26 | -50.91 |
Price to Earnings |
-- | 21.82 | -- |
Price-To-Book |
19.23 | 1.77 | 4.80 |
Cashflow ($ Mln)
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
Cash From Operating Activities
|
-27.88 | 27.59 | -14.53 |
|
Cash Flow from Investing Activities
|
-- | -10.65 | -19.54 |
|
Cash from Financing Activities
|
25.37 | -19.86 | 29.62 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- |
Ratios
Profitability Ratios
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
ROCE (%)
|
-219.95 | 7.33 | -53.14 |
|
ROE (%)
|
-385.07 | 8.26 | -50.91 |
|
ROA (%)
|
-84.05 | 4.47 | -19.14 |
|
EBIT Margin (%)
|
-- | 13.90 | -176.09 |
|
Net Margin (%)
|
-- | 11.60 | -170.10 |
|
Cash Profit Margin (%)
|
-- | 0.00 | 0.00 |
Growth Ratios
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
Revenue Growth (%)
|
-- | 13.17 | -40.26 |
|
EBIT Growth (%)
|
49.74 | 36.69 | 23.20 |
|
Net Profit Growth (%)
|
8.76 | 17.05 | 28.53 |
|
EPS Growth (%)
|
61.30 | 11.11 | 39.18 |
|
Book Value Growth (%)
|
-85.07 | 1.64 | 49.00 |
Valuation Ratios
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
Price / Earnings
|
-2.62 | 21.55 | -9.91 |
|
Price / Book Value
|
19.23 | 1.77 | 4.80 |
|
Dividend Yield (%)
|
0.00 | 2.06 | 0.00 |
|
EV/EBITDA
|
-3.02 | 9.87 | -6.23 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.24 | 0.01 | 0.03 |
|
Current Ratio
|
1.35 | 4.06 | 2.32 |
|
Quick Ratio
|
1.14 | 2.29 | 2.09 |
|
Interest Coverage
|
-1,313.75 | 26.73 | -16.87 |
Operating Efficiency Ratios
| PolyPid (PYPD) | Kamada - ADR | MediWound - ADR | |
|---|---|---|---|
|
Debtors to sales (%)
|
-- | 19.13 | 29.44 |
|
Asset Turnover
|
0.00 | 0.38 | 0.11 |
|
Receivable days
|
-- | 52.87 | 88.56 |
|
Inventory Days
|
-- | 287.45 | 90.41 |
|
Payable days
|
-- | 89.48 | 102.65 |
|
Cash Conversion Cycle
|
-- | 250.84 | 76.33 |